LXH-003

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameLXH-003
Drug Alias NameLXH-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLixin Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesLixin Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A